Advertisement
Screener

USANA HEALTH SCIENCES, INC. (USNA) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

1.5 / 5 stars · 32/110 Roast Me

USANA HEALTH SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

USANA HEALTH SCIENCES, INC. (USNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-01.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2017-03-01

  • USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2015-04-04 was 0.00%.
  • USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2014-03-29 was 0.00%.
  • USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2013-03-30 was 0.00%.
  • USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2016 was 0.00%.
  • USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2016 was 0.00%.
  • USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2015 was 0.00%.
  • USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2013 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2016-12-310.00%
10-K · filed 2017-03-01
2016-01-020.00%
10-K · filed 2017-03-01
2015-10-030.00%
10-Q · filed 2015-11-12
2015-07-040.00%
10-Q · filed 2015-08-12
2015-04-040.00%
10-Q · filed 2015-05-13
2015-01-030.00%
10-K · filed 2017-03-01
2014-09-270.00%
10-Q · filed 2015-11-12
2014-06-280.00%
10-Q · filed 2015-08-12
2014-03-290.00%
10-Q · filed 2015-05-13
2013-12-280.00%
10-K · filed 2016-03-01
2013-09-280.00%
10-Q · filed 2014-11-06
2013-06-290.00%
10-Q · filed 2014-08-05
2013-03-300.00%
10-Q · filed 2014-05-07
2012-12-290.00%
10-K · filed 2015-03-17
2011-12-310.00%
10-K · filed 2014-03-13
2011-01-010.00%
10-K · filed 2013-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Canopy Growth Corp (CGC)$0.395B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87